ARCHIVES

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

This article is from The Cancer Letter archive.

Vol. 03 No. 21 | May 27, 1977

Download PDF Visit The Full Archive

Related Articles

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

ACS Modifies Pap Test Guidelines

November 27, 1987

Panel Waffles On One Vs. Three Year Intervals For Pap Test, Agrees On when They Should Start

August 1, 1980